According to researches, glioblastoma (GBM) is a highly malignant brain tumor characterized by elevated BIRC3 expression, which is associated with tumor progression from low to high differentiation and resistance to temozolomide (TMZ) and radiation therapy, ultimately leading to reduced patient survival rates (100). This evidence concerns the gene BIRC3 and glioblastoma.